paxlovid-pf-07321332-ritonavir-covid-19-article-53-procedure-conditions-use-conditions-distribution_enDownload MEDICINAL PRODUCT FOR USE 1. Name of the medicinal product for use: PAXLOVID 2. Active substance(s): Nirmatrelvir and ritonavir 3. Pharmaceutical form: Film-coated tablets 4. Route of administration: Oral use…
Pfizer's oral COVID-19 antiviral, Paxlovid, would still be effective against the emerging Omicron variant, CEO Albert Bourla said. (Pfizer) The efficacy data for Pfizer’s oral COVID-19 drug now look so…
Synopsis: US drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licence to manufacture generic versions of oral…
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome generates 16 distinct non-structural proteins (nsp) that constitute the enzymes and accessory proteins responsible for virus replication once inside a host…